First, there is a body of literature indicating that the microbiome plays an important part in many conditions. The last one in this list of citations agrees with my hypothesis for the last 7 years: “Multi-kingdom gut microbiota analyses define CONDITION-X severity and in some case the syndrome.“
Citation |
---|
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study. Microorganisms (Microorganisms ) Vol: 9 Issue 6 Pages: Pub: 2021 Jun 7 Epub: 2021 Jun 7 Authors Kim HN , Joo EJ , Lee CW , Ahn KS , Kim HL , Park DI , Park SK , Summary Html Article Publication |
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut microbes (Gut Microbes ) Vol: 13 Issue 1 Pages: 1-15 Pub: 2021 Jan-Dec Epub: Authors Newsome RC , Gauthier J , Hernandez MC , Abraham GE , Robinson TO , Williams HB , Sloan M , Owings A , Laird H , Christian T , Pride Y , Wilson KJ , Hasan M , Parker A , Senitko M , Glover SC , Gharaibeh RZ , Jobin C , Summary Html Article Publication |
Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 638825 Pub: 2021 Epub: 2021 May 13 Authors Tian Y , Sun KY , Meng TQ , Ye Z , Guo SM , Li ZM , Xiong CL , Yin Y , Li HG , Zhou LQ , Summary Html Article Publication |
Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations. Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 761067 Pub: 2021 Epub: 2021 Nov 5 Authors Al Bataineh MT , Henschel A , Mousa M , Daou M , Waasia F , Kannout H , Khalili M , Kayasseh MA , Alkhajeh A , Uddin M , Alkaabi N , Tay GK , Feng SF , Yousef AF , Alsafar HS , Summary Publication |
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut (Gut ) Vol: Issue Pages: Pub: 2022 Jan 26 Epub: 2022 Jan 26 Authors Liu Q , Mak JWY , Su Q , Yeoh YK , Lui GC , Ng SSS , Zhang F , Li AYL , Lu W , Hui DS , Chan PK , Chan FKL , Ng SC , Summary Publication |
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy (Signal Transduct Target Ther ) Vol: 7 Issue 1 Pages: 143 Pub: 2022 Apr 29 Epub: 2022 Apr 29 Authors Wang B , Zhang L , Wang Y , Dai T , Qin Z , Zhou F , Zhang L , Summary Publication |
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology (Gastroenterology ) Vol: 159 Issue 3 Pages: 944-955.e8 Pub: 2020 Sep Epub: 2020 May 20 Authors Zuo T , Zhang F , Lui GCY , Yeoh YK , Li AYL , Zhan H , Wan Y , Chung ACK , Cheung CP , Chen N , Lai CKC , Chen Z , Tso EYK , Fung KSC , Chan V , Ling L , Joynt G , Hui DSC , Chan FKL , Chan PKS , Ng SC , Summary Publication |
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology (Gastroenterology ) Vol: 159 Issue 4 Pages: 1302-1310.e5 Pub: 2020 Oct Epub: 2020 Jun 26 Authors Zuo T , Zhan H , Zhang F , Liu Q , Tso EYK , Lui GCY , Chen N , Li A , Lu W , Chan FKL , Chan PKS , Ng SC , Summary Publication |
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Frontiers in medicine (Front Med (Lausanne) ) Vol: 7 Issue Pages: 389 Pub: 2020 Epub: 2020 Jul 7 Authors d`Ettorre G , Ceccarelli G , Marazzato M , Campagna G , Pinacchio C , Alessandri F , Ruberto F , Rossi G , Celani L , Scagnolari C , Mastropietro C , Trinchieri V , Recchia GE , Mauro V , Antonelli G , Pugliese F , Mastroianni CM , Summary Publication |
It Ain`t Over `Til It`s Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility. Digestive diseases and sciences (Dig Dis Sci ) Vol: Issue Pages: Pub: 2022 Mar 30 Epub: 2022 Mar 30 Authors Coles MJ , Masood M , Crowley MM , Hudgi A , Okereke C , Klein J , Summary Publication |
Integrated analysis of gut microbiome and host immune responses in COVID-19. Frontiers of medicine (Front Med ) Vol: 16 Issue 2 Pages: 263-275 Pub: 2022 Apr Epub: 2022 Mar 8 Authors Xu X , Zhang W , Guo M , Xiao C , Fu Z , Yu S , Jiang L , Wang S , Ling Y , Liu F , Tan Y , Chen S , Summary Publication |
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. Journal of internal medicine (J Intern Med ) Vol: 291 Issue 6 Pages: 801-812 Pub: 2022 Jun Epub: 2022 Mar 17 Authors Vestad B , Ueland T , Lerum TV , Dahl TB , Holm K , Barratt-Due A , Kåsine T , Dyrhol-Riise AM , Stiksrud B , Tonby K , Hoel H , Olsen IC , Henriksen KN , Tveita A , Manotheepan R , Haugli M , Eiken R , Berg Å , Halvorsen B , Lekva T , Ranheim T , Michelsen AE , Kildal AB , Johannessen A , Thoresen L , Skudal H , Kittang BR , Olsen RB , Ystrøm CM , Skei NV , Hannula R , Aballi S , Kvåle R , Skjønsberg OH , Aukrust P , Hov JR , Trøseid M , NOR-Solidarity study group. , Summary Publication |
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes. Nature communications (Nat Commun ) Vol: 13 Issue 1 Pages: 5235 Pub: 2022 Sep 6 Epub: 2022 Sep 6 Authors Ke S , Weiss ST , Liu YY , Summary Publication |
Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nature communications (Nat Commun ) Vol: 13 Issue 1 Pages: 6806 Pub: 2022 Nov 10 Epub: 2022 Nov 10 Authors Liu Q , Su Q , Zhang F , Tun HM , Mak JWY , Lui GC , Ng SSS , Ching JYL , Li A , Lu W , Liu C , Cheung CP , Hui DSC , Chan PKS , Chan FKL , Ng SC , Summary Publication |
Looking at what is statistically significant in samples uploaded to the citizen science site, we see that only BiomeSight has sufficient data. It identifies 36 taxa/bacteria at present. With more samples coming in, this may increase. Before looking at the bacteria, I like to look at the enzymes — why? different bacteria produce the same enzymes so it is an elegant way of clustering bacteria by what they produce.
KEGG Enzyme data
In this case, I am blown away on the number of statistically significant shifts! If you want more information about these enzymes, see BRENDA or/and Kyoto Encyclopedia of Genes and Genomes.
There are 197 with P < 0.001. Give there is 8000+ enzymes, that suggests around 8 may be false positives.
Enzyme Name | ECKEY | With Long COVID | Without Long COVID | T-Score | DF | Probability |
(S)-3-hydroxy-3-methylglutaryl-CoA acetoacetate-lyase (acetyl-CoA-forming) | 4.1.3.4 | 130357 | 52076 | 13.57 | 666 | P < 0.001 |
4-amino-5-aminomethyl-2-methylpyrimidine aminohydrolase | 3.5.99.2 | 151693 | 69126 | 13.48 | 666 | P < 0.001 |
dihydrourocanate:acceptor oxidoreductase | 1.3.99.33 | 135133 | 55921 | 13.44 | 666 | P < 0.001 |
nucleoside-triphosphate diphosphohydrolase | 3.6.1.9 | 145528 | 63523 | 13.38 | 666 | P < 0.001 |
poly(deoxyribonucleotide)-3′-hydroxyl:5′-phospho-poly(deoxyribonucleotide) ligase (ATP or NAD+) | 6.5.1.6 | 129475 | 51779 | 13.34 | 666 | P < 0.001 |
poly(deoxyribonucleotide)-3′-hydroxyl:5′-phospho-poly(deoxyribonucleotide) ligase (ATP, ADP or GTP) | 6.5.1.7 | 129475 | 51779 | 13.34 | 666 | P < 0.001 |
acetyl-CoA:kanamycin-B N6′-acetyltransferase | 2.3.1.82 | 128673 | 51662 | 13.32 | 666 | P < 0.001 |
acetyl-CoA:2-deoxystreptamine-antibiotic N3-acetyltransferase | 2.3.1.81 | 130200 | 53104 | 13.28 | 666 | P < 0.001 |
(1->4)-alpha-D-galacturonan reducing-end-disaccharide-lyase | 4.2.2.9 | 128038 | 50989 | 13.28 | 666 | P < 0.001 |
alpha-maltose-6′-phosphate 6-phosphoglucohydrolase | 3.2.1.122 | 130496 | 53951 | 13.28 | 666 | P < 0.001 |
D-serine ammonia-lyase (pyruvate-forming) | 4.3.1.18 | 128576 | 51987 | 13.23 | 666 | P < 0.001 |
ATP phosphohydrolase (ABC-type, iron(III) enterobactin-importing) | 7.2.2.17 | 130373 | 54180 | 13.15 | 666 | P < 0.001 |
protein-Npi-phospho-L-histidine:D-mannose Npi-phosphotransferase | 2.7.1.191 | 140701 | 62807 | 13.14 | 666 | P < 0.001 |
protein-Npi-phospho-L-histidine:D-mannitol Npi-phosphotransferase | 2.7.1.197 | 129284 | 53723 | 13.06 | 666 | P < 0.001 |
ADP-alpha-D-glucose:alpha-D-glucose-1-phosphate 4-alpha-D-glucosyltransferase (configuration-retaining) | 2.4.1.342 | 134654 | 58028 | 13.04 | 665 | P < 0.001 |
aryl-ester hydrolase | 3.1.1.2 | 151171 | 72377 | 13.02 | 666 | P < 0.001 |
ATP phosphohydrolase (ABC-type, Fe3+-transporting) | 7.2.2.7 | 142152 | 66111 | 12.86 | 666 | P < 0.001 |
palmitoyl-CoA hydrolase | 3.1.2.2 | 149499 | 71728 | 12.83 | 666 | P < 0.001 |
ATP:[protein]-L-tyrosine O-phosphotransferase (non-specific) | 2.7.10.2 | 131925 | 57360 | 12.75 | 666 | P < 0.001 |
D-psicose 3-epimerase | 5.1.3.30 | 143416 | 68284 | 12.74 | 666 | P < 0.001 |
D-tagatose 3-epimerase | 5.1.3.31 | 143416 | 68284 | 12.74 | 666 | P < 0.001 |
penicillin amidohydrolase | 3.5.1.11 | 139138 | 66165 | 12.62 | 666 | P < 0.001 |
D-aspartate:[beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n ligase (ADP-forming) | 6.3.1.12 | 145356 | 70261 | 12.57 | 666 | P < 0.001 |
2′-(5-triphosphoribosyl)-3′-dephospho-CoA:apo-[citrate (pro-3S)-lyase] 2′-(5-phosphoribosyl)-3′-dephospho-CoA-transferase | 2.7.7.61 | 149196 | 74697 | 12.46 | 666 | P < 0.001 |
ATP:3′-dephospho-CoA 5-triphospho-alpha-D-ribosyltransferase | 2.4.2.52 | 149957 | 75781 | 12.39 | 666 | P < 0.001 |
2,4,6/3,5-pentahydroxycyclohexanone 2-isomerase | 5.3.99.11 | 146254 | 73538 | 12.37 | 666 | P < 0.001 |
acetyl-CoA:citrate CoA-transferase | 2.8.3.10 | 150367 | 76318 | 12.36 | 666 | P < 0.001 |
L-aspartate:tRNAAsx ligase (AMP-forming) | 6.1.1.23 | 132939 | 61720 | 12.22 | 666 | P < 0.001 |
4-phospho-D-erythronate:NAD+ 3-oxidoreductase | 1.1.1.409 | 134073 | 62914 | 12.19 | 666 | P < 0.001 |
4-phospho-D-threonate:NAD+ 3-oxidoreductase | 1.1.1.408 | 134073 | 62914 | 12.19 | 666 | P < 0.001 |
poly(deoxyribonucleotide)-3′-hydroxyl:5′-phospho-poly(deoxyribonucleotide) ligase (ATP) | 6.5.1.1 | 143883 | 68128 | 12.15 | 666 | P < 0.001 |
ATP:D-erythronate 4-phosphotransferase | 2.7.1.220 | 133631 | 62696 | 12.13 | 666 | P < 0.001 |
ATP:D-threonate 4-phosphotransferase | 2.7.1.219 | 133631 | 62696 | 12.13 | 666 | P < 0.001 |
ATP:D-glycero-alpha-D-manno-heptose 7-phosphate 1-phosphotransferase | 2.7.1.168 | 156157 | 78491 | 11.99 | 666 | P < 0.001 |
2-lysophosphatidylcholine acylhydrolase | 3.1.1.5 | 160874 | 86814 | 11.71 | 666 | P < 0.001 |
UDP-alpha-D-glucose:1,2-diacyl-sn-glycerol 3-alpha-D-glucosyltransferase | 2.4.1.337 | 159960 | 87248 | 11.57 | 666 | P < 0.001 |
N-succinyl-LL-2,6-diaminoheptanedioate amidohydrolase | 3.5.1.18 | 151482 | 82849 | 11.49 | 666 | P < 0.001 |
acetate:holo-[citrate-(pro-3S)-lyase] ligase (AMP-forming) | 6.2.1.22 | 163245 | 90493 | 11.44 | 666 | P < 0.001 |
D-tagatose 1,6-bisphosphate D-glyceraldehyde-3-phosphate-lyase (glycerone-phosphate-forming) | 4.1.2.40 | 140814 | 72879 | 11.44 | 666 | P < 0.001 |
L-iditol:NAD+ 2-oxidoreductase | 1.1.1.14 | 181524 | 109886 | 11.34 | 666 | P < 0.001 |
alkylated-DNA glycohydrolase (releasing methyladenine and methylguanine) | 3.2.2.21 | 172169 | 89028 | 11.33 | 666 | P < 0.001 |
oligosaccharide 6-alpha-glucohydrolase | 3.2.1.10 | 161628 | 93712 | 11.12 | 666 | P < 0.001 |
(3S)-citryl-CoA oxaloacetate-lyase (acetyl-CoA-forming) | 4.1.3.34 | 185375 | 105009 | 10.73 | 666 | P < 0.001 |
S-adenosyl-L-methionine:tRNA (adenine22-N1)-methyltransferase | 2.1.1.217 | 157938 | 92817 | 10.69 | 666 | P < 0.001 |
S-adenosyl-L-methionine:16S rRNA (cytidine1409-2′-O)-methyltransferase | 2.1.1.227 | 183689 | 114027 | 10.56 | 666 | P < 0.001 |
S-adenosyl-L-methionine:23S rRNA (cytidine1920-2′-O)-methyltransferase | 2.1.1.226 | 183689 | 114027 | 10.56 | 666 | P < 0.001 |
sn-glycerol 3-phosphate:quinone oxidoreductase | 1.1.5.3 | 177064 | 110486 | 10.54 | 666 | P < 0.001 |
L-glutamate:tRNAGlx ligase (AMP-forming) | 6.1.1.24 | 165448 | 97402 | 10.38 | 666 | P < 0.001 |
D-glycero-D-manno-heptose 7-phosphate aldose-ketose-isomerase | 5.3.1.28 | 213475 | 135248 | 10.25 | 666 | P < 0.001 |
beta-D-glucose 1,6-phosphomutase | 5.4.2.6 | 253383 | 169933 | 8.98 | 666 | P < 0.001 |
type II site-specific deoxyribonuclease | 3.1.21.4 | 245864 | 165266 | 8.77 | 666 | P < 0.001 |
uroporphyrinogen-III carboxy-lyase (coproporphyrinogen-III-forming) | 4.1.1.37 | 266562 | 184417 | 8.59 | 666 | P < 0.001 |
ATP phosphohydrolase (ABC-type, Ni2+-importing) | 7.2.2.11 | 141054 | 86367 | 8.56 | 666 | P < 0.001 |
acetyl-CoA:oxalate CoA-transferase | 2.8.3.19 | 133160 | 80149 | 8.41 | 666 | P < 0.001 |
5-phospho-alpha-D-ribose 1,2-cyclic phosphate 1,2-diphosphophosphohydrolase | 3.1.4.57 | 134813 | 82183 | 8.33 | 666 | P < 0.001 |
Carboxypeptidase Taq | 3.4.17.19 | 136153 | 84074 | 8.31 | 666 | P < 0.001 |
(2E)-2-enoyl-CoA:NADP+ 4-oxidoreductase | 1.3.1.34 | 134146 | 81935 | 8.31 | 666 | P < 0.001 |
2′-deoxyribonucleoside 5′-monophosphate phosphohydrolase | 3.1.3.89 | 136444 | 84251 | 8.19 | 666 | P < 0.001 |
cellobiose 2-epimerase | 5.1.3.11 | 224933 | 147685 | 8.17 | 666 | P < 0.001 |
type III site-specific deoxyribonuclease | 3.1.21.5 | 200155 | 141657 | 8.10 | 666 | P < 0.001 |
D-galactonate hydro-lyase (2-dehydro-3-deoxy-D-galactonate-forming) | 4.2.1.6 | 138933 | 88181 | 8.02 | 666 | P < 0.001 |
protein-Npi-phospho-L-histidine:maltose Npi-phosphotransferase | 2.7.1.208 | 138609 | 88325 | 7.98 | 666 | P < 0.001 |
L-aspartate:NAD(P)+ oxidoreductase (deaminating) | 1.4.1.21 | 245150 | 169471 | 7.90 | 666 | P < 0.001 |
protein-Npi-phospho-L-histidine:sucrose Npi-phosphotransferase | 2.7.1.211 | 144741 | 96084 | 7.85 | 666 | P < 0.001 |
protein-Npi-phospho-L-histidine:N-acetyl-D-glucosamine Npi-phosphotransferase | 2.7.1.193 | 152088 | 103970 | 7.64 | 666 | P < 0.001 |
N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-epimerase | 5.1.3.26 | 259434 | 182387 | 7.64 | 666 | P < 0.001 |
UDP-sugar sugarphosphohydrolase | 3.6.1.45 | 156303 | 108944 | 7.63 | 666 | P < 0.001 |
rubredoxin:superoxide oxidoreductase | 1.15.1.2 | 147572 | 101699 | 7.40 | 666 | P < 0.001 |
UDP-2-acetamido-2,6-dideoxy-L-talose:NADP+ oxidoreductase | 1.1.1.367 | 244790 | 176296 | 7.33 | 666 | P < 0.001 |
(4-O-methyl)-D-glucuronate—lignin ester hydrolase | 3.1.1.117 | 265763 | 190685 | 7.31 | 666 | P < 0.001 |
alkylated-DNA glycohydrolase (releasing methyladenine and methylguanine) | 3.2.2.20 | 306951 | 231407 | 7.30 | 666 | P < 0.001 |
S-adenosyl-L-methionine:16S rRNA (cytosine967-C5)-methyltransferase | 2.1.1.176 | 192348 | 143978 | 7.28 | 666 | P < 0.001 |
ATP:molybdopterin-synthase adenylyltransferase | 2.7.7.80 | 297993 | 218788 | 7.25 | 666 | P < 0.001 |
UDP-N-acetyl-alpha-D-glucosamine hydro-lyase (inverting; UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose-forming) | 4.2.1.115 | 287717 | 211984 | 7.24 | 666 | P < 0.001 |
UDP-2-acetamido-2,6-dideoxy-beta-L-talose 2-epimerase | 5.1.3.28 | 245857 | 178308 | 7.23 | 666 | P < 0.001 |
ATP phosphohydrolase (ABC-type, molybdate-importing) | 7.3.2.5 | 157815 | 111902 | 7.18 | 666 | P < 0.001 |
sucrose:(1->4)-alpha-D-glucan 4-alpha-D-glucosyltransferase | 2.4.1.4 | 148095 | 102284 | 7.16 | 666 | P < 0.001 |
UDP-N-acetyl-2-amino-2-deoxy-alpha-D-glucuronate:NAD+ 3-oxidoreductase | 1.1.1.335 | 172209 | 124841 | 7.08 | 666 | P < 0.001 |
an acyl-[acyl-carrier protein]:phosphate acyltransferase | 2.3.1.274 | 185445 | 139090 | 7.05 | 666 | P < 0.001 |
FMNH2:NAD(P)+ oxidoreductase | 1.5.1.39 | 156478 | 107179 | 7.02 | 666 | P < 0.001 |
cellobiose:phosphate alpha-D-glucosyltransferase | 2.4.1.20 | 165795 | 117785 | 6.98 | 666 | P < 0.001 |
4-beta-D-xylan xylohydrolase | 3.2.1.37 | 308412 | 233667 | 6.87 | 666 | P < 0.001 |
crossover junction endodeoxyribonuclease | 3.1.21.10 | 341116 | 260719 | 6.82 | 666 | P < 0.001 |
nucleoside-2′,3′-cyclic-phosphate 3′-nucleotidohydrolase | 3.1.4.16 | 321464 | 242830 | 6.82 | 666 | P < 0.001 |
UDP-glucuronate 4-epimerase | 5.1.3.6 | 280650 | 207501 | 6.80 | 666 | P < 0.001 |
S-adenosyl-L-methionine:precorrin-2 C20-methyltransferase | 2.1.1.130 | 293271 | 227548 | 6.79 | 666 | P < 0.001 |
S-adenosyl-L-methionine:cobalt-factor-II C20-methyltransferase | 2.1.1.151 | 293124 | 227408 | 6.78 | 666 | P < 0.001 |
dipeptidase E | 3.4.13.21 | 204290 | 149503 | 6.73 | 666 | P < 0.001 |
GTP:alpha-D-mannose-1-phosphate guanylyltransferase | 2.7.7.13 | 331462 | 252998 | 6.69 | 666 | P < 0.001 |
ATP:1,2-diacyl-sn-glycerol 3-phosphotransferase | 2.7.1.107 | 333291 | 259697 | 6.61 | 666 | P < 0.001 |
L-selenocysteine selenide-lyase (L-alanine-forming) | 4.4.1.16 | 337172 | 260622 | 6.56 | 666 | P < 0.001 |
1,4-beta-D-mannooligosaccharide:phosphate alpha-D-mannosyltransferase | 2.4.1.319 | 300427 | 227352 | 6.54 | 666 | P < 0.001 |
4-O-beta-D-mannopyranosyl-N-acetyl-D-glucosamine:phosphate alpha-D-mannosyltransferase | 2.4.1.320 | 300427 | 227352 | 6.54 | 666 | P < 0.001 |
sortase B | 3.4.22.71 | 161358 | 119363 | 6.52 | 666 | P < 0.001 |
cobalt-precorrin 5A acylhydrolase | 3.7.1.12 | 160731 | 118900 | 6.48 | 666 | P < 0.001 |
6-carboxy-5,6,7,8-tetrahydropterin ammonia-lyase | 4.3.99.3 | 329010 | 253328 | 6.47 | 666 | P < 0.001 |
precorrin-8 11,12-methylmutase | 5.4.99.60 | 161359 | 119806 | 6.46 | 666 | P < 0.001 |
precorrin-8X 11,12-methylmutase | 5.4.99.61 | 161359 | 119806 | 6.46 | 666 | P < 0.001 |
UDP-alpha-D-glucose:NAD+ 6-oxidoreductase | 1.1.1.22 | 341877 | 267968 | 6.45 | 666 | P < 0.001 |
4-O-beta-D-mannopyranosyl-D-glucopyranose:phosphate alpha-D-mannosyltransferase | 2.4.1.281 | 294563 | 221546 | 6.44 | 666 | P < 0.001 |
O-acetyl-ADP-D-ribose carboxylesterase | 3.1.1.106 | 232755 | 178380 | 6.39 | 666 | P < 0.001 |
2′-deoxyribonucleoside-5′-diphosphate:thioredoxin-disulfide 2′-oxidoreductase | 1.17.4.1 | 355018 | 281224 | 6.39 | 666 | P < 0.001 |
3′-ribonucleotide phosphohydrolase | 3.1.3.6 | 303202 | 229568 | 6.38 | 666 | P < 0.001 |
acetyl-CoA:alkane-alpha,omega-diamine N-acetyltransferase | 2.3.1.57 | 341806 | 269466 | 6.32 | 666 | P < 0.001 |
5,10-methylenetetrahydrofolate:glycine hydroxymethyltransferase | 2.1.2.1 | 356606 | 283241 | 6.30 | 666 | P < 0.001 |
carbonic acid hydro-lyase (carbon-dioxide-forming) | 4.2.1.1 | 321295 | 248957 | 6.29 | 666 | P < 0.001 |
L-isoleucine:tRNAIle ligase (AMP-forming) | 6.1.1.5 | 364094 | 292209 | 6.24 | 666 | P < 0.001 |
DNA-6-O-methylguanine/DNA-4-O-methylthymine:[protein]-L-cysteine S-methyltransferase | 2.1.1.63 | 365615 | 293975 | 6.16 | 666 | P < 0.001 |
NADH:hydroperoxide oxidoreductase | 1.11.1.26 | 323275 | 252045 | 6.11 | 666 | P < 0.001 |
L-glutamate:tRNAGlu ligase (AMP-forming) | 6.1.1.17 | 321496 | 262066 | 6.08 | 666 | P < 0.001 |
bleomycin hydrolase | 3.4.22.40 | 314461 | 243175 | 6.08 | 666 | P < 0.001 |
L-cysteine-S-conjugate thiol-lyase (deaminating; 2-aminoprop-2-enoate-forming) | 4.4.1.13 | 363963 | 293237 | 6.08 | 666 | P < 0.001 |
UDP-alpha-D-glucose:alpha-D-galactose-1-phosphate uridylyltransferase | 2.7.7.12 | 170072 | 129650 | 6.05 | 666 | P < 0.001 |
peptidoglycan amidohydrolase | 3.5.1.28 | 363233 | 293964 | 5.99 | 666 | P < 0.001 |
adenine-DNA deoxyribohydrolase (adenine-releasing) | 3.2.2.31 | 355124 | 285300 | 5.95 | 666 | P < 0.001 |
D-phosphoglycerate 2,3-phosphomutase (2,3-diphosphoglycerate-dependent) | 5.4.2.11 | 319582 | 250208 | 5.95 | 666 | P < 0.001 |
tRNA N6-(3-methylbut-2-en-1-yl)-adenine37:sulfur-(sulfur carrier),S-adenosyl-L-methionine C2-(methylsulfanyl)transferase | 2.8.4.3 | 370115 | 301224 | 5.93 | 666 | P < 0.001 |
10-formyltetrahydrofolate:5′-phosphoribosylglycinamide N-formyltransferase | 2.1.2.2 | 363374 | 295358 | 5.89 | 666 | P < 0.001 |
peptidase Do | 3.4.21.107 | 276660 | 224637 | 5.87 | 666 | P < 0.001 |
poly(deoxyribonucleotide)-3′-hydroxyl:5′-phospho-poly(deoxyribonucleotide) ligase (NAD+) | 6.5.1.2 | 372463 | 304412 | 5.85 | 666 | P < 0.001 |
methionyl aminopeptidase | 3.4.11.18 | 372462 | 304426 | 5.85 | 666 | P < 0.001 |
prenyl-diphosphate:adenine37 in tRNA prenyltransferase | 2.5.1.75 | 371863 | 303924 | 5.84 | 666 | P < 0.001 |
ATP:pyridoxal 5′-phosphotransferase | 2.7.1.35 | 329032 | 261786 | 5.80 | 666 | P < 0.001 |
L-rhamnose aldose-ketose-isomerase | 5.3.1.14 | 307393 | 241401 | 5.80 | 666 | P < 0.001 |
peptide-methionine:thioredoxin-disulfide S-oxidoreductase [methionine (R)-S-oxide-forming] | 1.8.4.12 | 257798 | 203935 | 5.76 | 666 | P < 0.001 |
deoxyribonuclease IV | 3.1.21.2 | 353617 | 287404 | 5.73 | 666 | P < 0.001 |
alpha-L-rhamnoside rhamnohydrolase | 3.2.1.40 | 318053 | 252744 | 5.68 | 666 | P < 0.001 |
ATP phosphohydrolase (ABC-type, Zn2+-importing) | 7.2.2.20 | 331254 | 264520 | 5.66 | 666 | P < 0.001 |
L-rhamnulose-1-phosphate (S)-lactaldehyde-lyase (glycerone-phosphate-forming) | 4.1.2.19 | 307632 | 243590 | 5.63 | 666 | P < 0.001 |
6-deoxy-6-sulfo-D-fructose:D-glyceraldehyde-3-phosphate glyceronetransferase | 2.2.1.14 | 173 | 33 | 5.60 | 41 | P < 0.001 |
ATP:L-rhamnulose 1-phosphotransferase | 2.7.1.5 | 319257 | 255641 | 5.50 | 666 | P < 0.001 |
ATP:glycerol 3-phosphotransferase | 2.7.1.30 | 271460 | 223970 | 5.50 | 666 | P < 0.001 |
(R)-S-lactoylglutathione methylglyoxal-lyase (isomerizing; glutathione-forming) | 4.4.1.5 | 341379 | 280079 | 5.36 | 666 | P < 0.001 |
exodeoxyribonuclease V | 3.1.11.5 | 224710 | 181406 | 5.36 | 666 | P < 0.001 |
NAD(H) phosphohydrolase | 3.6.1.22 | 335898 | 275329 | 5.26 | 666 | P < 0.001 |
L-alanyl-D-glutamate epimerase | 5.1.1.20 | 211984 | 168065 | 5.24 | 666 | P < 0.001 |
CTP:2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase | 2.7.7.60 | 342240 | 289619 | 5.12 | 666 | P < 0.001 |
beta-D-fructofuranoside fructohydrolase | 3.2.1.26 | 204815 | 169106 | 4.91 | 666 | P < 0.001 |
beta-lactam hydrolase | 3.5.2.6 | 328892 | 276729 | 4.76 | 666 | P < 0.001 |
GTP 7,8-8,9-dihydrolase (diphosphate-forming) | 3.5.4.25 | 363191 | 310173 | 4.54 | 666 | P < 0.001 |
D-ribulose 5-phosphate formate-lyase (L-3,4-dihydroxybutan-2-one 4-phosphate-forming) | 4.1.99.12 | 363190 | 310173 | 4.54 | 666 | P < 0.001 |
5-amino-6-(D-ribitylamino)uracil butanedionetransferase | 2.5.1.78 | 363021 | 310046 | 4.54 | 666 | P < 0.001 |
5-amino-6-(5-phospho-D-ribitylamino)uracil:NADP+ 1′-oxidoreductase | 1.1.1.193 | 356070 | 302730 | 4.53 | 666 | P < 0.001 |
2,5-diamino-6-hydroxy-4-(5-phospho-D-ribosylamino)pyrimidine 2-aminohydrolase | 3.5.4.26 | 356070 | 302730 | 4.53 | 666 | P < 0.001 |
D-mannose-6-phosphate aldose-ketose-isomerase | 5.3.1.8 | 349959 | 298038 | 4.51 | 666 | P < 0.001 |
5′-ribonucleotide phosphohydrolase | 3.1.3.5 | 363417 | 312818 | 4.40 | 666 | P < 0.001 |
peptidoglycan-N-acetylglucosamine amidohydrolase | 3.5.1.104 | 334065 | 289136 | 4.35 | 666 | P < 0.001 |
fragilysin | 3.4.24.74 | 7726 | 2137 | 4.30 | 487 | P < 0.001 |
UTP:alpha-D-glucose-1-phosphate uridylyltransferase | 2.7.7.9 | 180042 | 146829 | 4.27 | 666 | P < 0.001 |
adenosylcobinamide-GDP:alpha-ribazole ribazoletransferase | 2.7.8.26 | 336101 | 289980 | 4.27 | 666 | P < 0.001 |
Fe(II):oxygen oxidoreductase ([FeO(OH)]core-producing) | 1.16.3.2 | 343886 | 295642 | 4.23 | 666 | P < 0.001 |
D-stereospecific aminopeptidase | 3.4.11.19 | 146732 | 114608 | 4.23 | 666 | P < 0.001 |
D-glycerate:NAD+ oxidoreductase | 1.1.1.29 | 304790 | 258395 | 4.21 | 666 | P < 0.001 |
ATP:dTMP phosphotransferase | 2.7.4.9 | 182727 | 149804 | 4.20 | 666 | P < 0.001 |
ATP:UDP-N-acetyl-alpha-D-glucosamine 3′-phosphotransferase | 2.7.1.176 | 7304 | 3121 | 4.15 | 664 | P < 0.001 |
L-histidinol:NAD+ oxidoreductase | 1.1.1.23 | 360776 | 312129 | 4.13 | 666 | P < 0.001 |
queuosine34 in tRNA:acceptor oxidoreductase | 1.17.99.6 | 365803 | 318709 | 4.13 | 666 | P < 0.001 |
L-lysine:tRNALys ligase (AMP-forming) | 6.1.1.6 | 372837 | 325856 | 4.10 | 666 | P < 0.001 |
(R)-lactate hydro-lyase (adding N-acetyl-D-glucosamine 6-phosphate; N-acetylmuramate 6-phosphate-forming) | 4.2.1.126 | 315409 | 268045 | 4.06 | 666 | P < 0.001 |
CoA-[4′-phosphopantetheine]:apo-[acyl-carrier protein] 4′-pantetheinephosphotransferase | 2.7.8.7 | 170465 | 139721 | 4.06 | 666 | P < 0.001 |
D-altronate hydro-lyase (2-dehydro-3-deoxy-D-gluconate-forming) | 4.2.1.7 | 307568 | 262854 | 4.05 | 666 | P < 0.001 |
(6R)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide 6-epimerase | 5.1.99.6 | 373721 | 327886 | 3.98 | 666 | P < 0.001 |
UTP:L-glutamine amido-ligase (ADP-forming) | 6.3.4.2 | 369633 | 324526 | 3.96 | 666 | P < 0.001 |
beta-D-4-deoxy-Delta4-GlcAp-(1->3)-beta-D-GalNAc6S hydrolase | 3.2.1.180 | 300245 | 258391 | 3.94 | 666 | P < 0.001 |
D-erythro-1-(imidazol-4-yl)glycerol-3-phosphate hydro-lyase [3-(imidazol-4-yl)-2-oxopropyl-phosphate-forming] | 4.2.1.19 | 361792 | 316233 | 3.94 | 666 | P < 0.001 |
1-(5-phospho-beta-D-ribosyl)-ATP:diphosphate phospho-alpha-D-ribosyl-transferase | 2.4.2.17 | 361822 | 316271 | 3.94 | 666 | P < 0.001 |
2-phospho-4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol CMP-lyase (cyclizing; 2-C-methyl-D-erythritol 2,4-cyclodiphosphate-forming) | 4.6.1.12 | 375199 | 329906 | 3.93 | 666 | P < 0.001 |
1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide aldose-ketose-isomerase | 5.3.1.16 | 361727 | 316261 | 3.93 | 666 | P < 0.001 |
[poly-N-acetyl-D-glucosaminyl-(1->4)-(N-acetyl-D-muramoylpentapeptide)]-diphosphoundecaprenol:[N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide]-diphosphoundecaprenol disaccharidetransferase | 2.4.1.129 | 367331 | 322381 | 3.93 | 666 | P < 0.001 |
5-[(5-phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate-lyase (L-glutamine-hydrolysing; 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide-forming) | 4.3.2.10 | 363190 | 317925 | 3.91 | 666 | P < 0.001 |
dTDP-alpha-D-glucose 4,6-hydro-lyase (dTDP-4-dehydro-6-deoxy-alpha-D-glucose-forming) | 4.2.1.46 | 363385 | 318389 | 3.90 | 666 | P < 0.001 |
ATP:(d)CMP phosphotransferase | 2.7.4.25 | 370117 | 325801 | 3.88 | 666 | P < 0.001 |
L-histidinol-phosphate:2-oxoglutarate aminotransferase | 2.6.1.9 | 372117 | 327934 | 3.85 | 666 | P < 0.001 |
5,10-methylenetetrahydrofolate,FADH2:dUMP C-methyltransferase | 2.1.1.148 | 143685 | 115112 | 3.81 | 666 | P < 0.001 |
orotidine-5′-phosphate carboxy-lyase (UMP-forming) | 4.1.1.23 | 376841 | 333051 | 3.81 | 666 | P < 0.001 |
N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) | 6.3.5.3 | 376690 | 332992 | 3.80 | 666 | P < 0.001 |
alpha-D-galactoside galactohydrolase | 3.2.1.22 | 351869 | 309262 | 3.80 | 666 | P < 0.001 |
oligonucleotidase | 3.1.13.3 | 361085 | 318401 | 3.79 | 666 | P < 0.001 |
ATP:pseudouridine 5′-phosphotransferase | 2.7.1.83 | 143192 | 114831 | 3.78 | 666 | P < 0.001 |
citrate(isocitrate) hydro-lyase (cis-aconitate-forming) | 4.2.1.3 | 370344 | 327004 | 3.78 | 666 | P < 0.001 |
adenosine-3′(2′),5′-bisphosphate 3′(2′)-phosphohydrolase | 3.1.3.7 | 363418 | 321345 | 3.74 | 666 | P < 0.001 |
adenylyl-molybdopterin:molybdate molybdate transferase (AMP-forming) | 2.10.1.1 | 155862 | 128309 | 3.71 | 666 | P < 0.001 |
sn-glycerol-3-phosphate:NAD(P)+ 2-oxidoreductase | 1.1.1.94 | 370438 | 328604 | 3.70 | 666 | P < 0.001 |
isocitrate:NADP+ oxidoreductase (decarboxylating) | 1.1.1.42 | 361230 | 319382 | 3.70 | 666 | P < 0.001 |
short-chain acyl-CoA:electron-transfer flavoprotein 2,3-oxidoreductase | 1.3.8.1 | 140972 | 113231 | 3.70 | 666 | P < 0.001 |
acetyl-CoA:oxaloacetate C-acetyltransferase [thioester-hydrolysing, (pro-S)-carboxymethyl-forming] | 2.3.3.1 | 362515 | 321195 | 3.65 | 666 | P < 0.001 |
UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose hydrolase | 3.6.1.57 | 5601 | 2056 | 3.64 | 644 | P < 0.001 |
D-mannonate hydro-lyase (2-dehydro-3-deoxy-D-gluconate-forming) | 4.2.1.8 | 329439 | 288135 | 3.63 | 666 | P < 0.001 |
ribonuclease M5 | 3.1.26.8 | 146813 | 119961 | 3.60 | 666 | P < 0.001 |
(S)-4-hydroxymandelate:oxygen 1-oxidoreductase | 1.1.3.46 | 148308 | 122183 | 3.58 | 666 | P < 0.001 |
S-adenosyl-L-methionine:tRNA (carboxymethyluridine34-5-O)-methyltransferase | 2.1.1.229 | 86 | 34 | 3.50 | 87 | P < 0.001 |
5,10-methylenetetrahydrofolate:tRNA (uracil54-C5)-methyltransferase | 2.1.1.74 | 146047 | 120006 | 3.48 | 666 | P < 0.001 |
aldehyde:ferredoxin oxidoreductase | 1.2.7.5 | 140099 | 114474 | 3.47 | 666 | P < 0.001 |
cobalt-precorrin-6B:NAD+ oxidoreductase | 1.3.1.106 | 150101 | 125120 | 3.41 | 666 | P < 0.001 |
precorrin-6B:NADP+ oxidoreductase | 1.3.1.54 | 150101 | 125120 | 3.41 | 666 | P < 0.001 |
(3S)-3-hydroxyacyl-CoA hydro-lyase | 4.2.1.17 | 146259 | 121343 | 3.40 | 666 | P < 0.001 |
coproporphyrinogen-III:S-adenosyl-L-methionine oxidoreductase (decarboxylating) | 1.3.98.3 | 183567 | 156750 | 3.31 | 666 | P < 0.001 |
Looking at the weaker statistical significance (where we expect 80 to be false positive) we have just 87 items. In other words, the ones below should likely be excluded from any analysis
Enzyme Name | ECKEY | With Long COVID | Without Long COVID | T-Score | DF | Probability |
protein-Npi-phospho-L-histidine:D-glucose Npi-phosphotransferase | 2.7.1.199 | 150395 | 126046 | 3.30 | 666 | P < 0.01 |
ATP:4-methyl-5-(2-hydroxyethyl)thiazole 2-phosphotransferase | 2.7.1.50 | 189360 | 164062 | 3.30 | 666 | P < 0.01 |
D-glucose-6-phosphate:NAD+ oxidoreductase | 1.1.1.361 | 368 | 88 | 3.26 | 359 | P < 0.01 |
ATP:alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol 3-phosphotransferase | 2.7.1.181 | 386 | 91 | 3.26 | 346 | P < 0.01 |
S-adenosyl-L-methionine:3-O-phospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol 3-phospho-methyltransferase | 2.1.1.294 | 386 | 91 | 3.26 | 346 | P < 0.01 |
S-adenosyl-L-methionine:23S rRNA (guanine745-N1)-methyltransferase | 2.1.1.187 | 147722 | 123211 | 3.25 | 666 | P < 0.01 |
kanosamine-6-phosphate phosphohydrolase | 3.1.3.92 | 364 | 88 | 3.25 | 363 | P < 0.01 |
kanosamine 6-phosphate:2-oxoglutarate aminotransferase | 2.6.1.104 | 368 | 92 | 3.24 | 365 | P < 0.01 |
ATP:L-glutamine N5-phosphotransferase | 2.7.3.13 | 241 | 33 | 3.23 | 54 | P < 0.01 |
GDP-beta-L-fucose:beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol alpha-1,2-fucosyltransferase | 2.4.1.308 | 390 | 89 | 3.22 | 326 | P < 0.01 |
UDP-alpha-D-galactose:N-acetyl-alpha-D-galactosaminyl-R beta-1,3-galactosyltransferase (configuration-inverting) | 2.4.1.122 | 390 | 89 | 3.22 | 326 | P < 0.01 |
UDP-alpha-D-glucose:N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol beta-1,3-glucosyltransferase | 2.4.1.305 | 390 | 89 | 3.22 | 326 | P < 0.01 |
UDP-N-acetyl-alpha-D-galactosamine:N-acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol alpha-1,3-N-acetyl-D-galactosyltransferase | 2.4.1.306 | 390 | 89 | 3.22 | 326 | P < 0.01 |
fluoroacetyl-CoA hydrolase | 3.1.2.29 | 242821 | 211022 | 3.20 | 666 | P < 0.01 |
GDP-alpha-D-mannose:alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol 2,3-alpha-mannosyltransferase (configuration-retaining) | 2.4.1.371 | 387 | 97 | 3.20 | 347 | P < 0.01 |
GDP-alpha-D-mannose:alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 3-alpha-mannosyltransferase (configuration-retaining) | 2.4.1.349 | 387 | 97 | 3.20 | 347 | P < 0.01 |
carbamoyl-phosphate:L-ornithine carbamoyltransferase | 2.1.3.3 | 193666 | 169029 | 3.19 | 666 | P < 0.01 |
ATP:L-homoserine O-phosphotransferase | 2.7.1.39 | 169424 | 144404 | 3.19 | 666 | P < 0.01 |
GDP-alpha-D-mannose:N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 3-alpha-mannosyltransferase (configuration-retaining) | 2.4.1.348 | 386 | 98 | 3.18 | 346 | P < 0.01 |
16S rRNA-uridine516 uracil mutase | 5.4.99.19 | 191228 | 167210 | 3.17 | 666 | P < 0.01 |
2,3-dihydroxybenzoate:oxygen 3,4-oxidoreductase (ring-opening) | 1.13.11.14 | 56 | 24 | 3.17 | 72 | P < 0.01 |
ATP:molybdopterin adenylyltransferase | 2.7.7.75 | 150983 | 127838 | 3.16 | 666 | P < 0.01 |
GDP-beta-L-colitose:beta-D-galactopyranosyl-(1->3)-N-acetyl-D-glucosamine L-colitosyltransferase (configuration-inverting) | 2.4.1.341 | 391 | 96 | 3.16 | 326 | P < 0.01 |
pyrimidine-nucleoside:phosphate (2′-deoxy)-alpha-D-ribosyltransferase | 2.4.2.2 | 160966 | 137755 | 3.13 | 666 | P < 0.01 |
ATP phosphohydrolase (ABC-type, D-galactose-importing) | 7.5.2.11 | 150190 | 126661 | 3.13 | 666 | P < 0.01 |
protein-Npi-phospho-L-histidine:D-fructose Npi-phosphotransferase | 2.7.1.202 | 150170 | 127151 | 3.12 | 666 | P < 0.01 |
diphosphate phosphohydrolase | 3.6.1.1 | 204902 | 180774 | 3.10 | 666 | P < 0.01 |
2-oxo-acid carboxy-lyase (aldehyde-forming) | 4.1.1.1 | 356 | 95 | 3.09 | 358 | P < 0.01 |
NAD+:diphthamide-[translation elongation factor 2] N-(ADP-D-ribosyl)transferase | 2.4.2.36 | 391 | 103 | 3.08 | 326 | P < 0.01 |
GDP-4-dehydro-alpha-D-rhamnose 3-hydro-lyase | 4.2.1.168 | 391 | 103 | 3.08 | 326 | P < 0.01 |
acetyl-CoA:L-glutamate N-acetyltransferase | 2.3.1.1 | 198282 | 174552 | 3.07 | 666 | P < 0.01 |
(8S)-3′,8-cyclo-7,8-dihydroguanosine 5′-triphosphate lyase (cyclic pyranopterin phosphate-forming) | 4.6.1.17 | 164816 | 142092 | 3.06 | 666 | P < 0.01 |
GTP 3′,8-cyclase [(8S)-3′,8-cyclo-7,8-dihydroguanosine 5′-triphosphate-forming] | 4.1.99.22 | 207283 | 180149 | 3.05 | 666 | P < 0.01 |
ADP-L-glycero-D-manno-heptose 6-epimerase | 5.1.3.20 | 33154 | 22635 | 3.03 | 666 | P < 0.01 |
malonyl-CoA:malonyl-CoA malonyltransferase (decarboxylating, phloroglucinol-forming) | 2.3.1.253 | 56 | 9 | 3.03 | 47 | P < 0.01 |
N2-acetyl-L-ornithine:L-glutamate N-acetyltransferase | 2.3.1.35 | 195917 | 172469 | 3.03 | 666 | P < 0.01 |
dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose:2-oxoglutarate aminotransferase | 2.6.1.106 | 48 | 25 | 3.01 | 61 | P < 0.01 |
L-threonine ammonia-lyase (2-oxobutanoate-forming) | 4.3.1.19 | 287308 | 259880 | 3.01 | 666 | P < 0.01 |
acetyl-CoA:dTDP-4-amino-4,6-dideoxy-alpha-D-glucose N-acetyltransferase | 2.3.1.209 | 391 | 109 | 3.01 | 326 | P < 0.01 |
acetyl-CoA:GDP-4-amino-4,6-dideoxy-alpha-D-mannose N-acetyltransferase | 2.3.1.227 | 391 | 109 | 3.01 | 326 | P < 0.01 |
acetyl-CoA:polysialic-acid O-acetyltransferase | 2.3.1.136 | 391 | 109 | 3.01 | 326 | P < 0.01 |
UDP-alpha-D-galactose:N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 3-beta-galactosyltransferase (configuration-inverting) | 2.4.1.303 | 391 | 109 | 3.01 | 326 | P < 0.01 |
phosphoenolpyruvate:protein-L-histidine Npi-phosphotransferase | 2.7.3.9 | 198327 | 175154 | 2.99 | 666 | P < 0.01 |
beta-D-galactopyranosyl-(1->3)-N-acetyl-D-hexosamine:phosphate galactosyltransferase | 2.4.1.211 | 157215 | 134837 | 2.98 | 666 | P < 0.01 |
acyl phosphoate:sn-glycerol 3-phosphate acyltransferase | 2.3.1.275 | 188180 | 165885 | 2.97 | 666 | P < 0.01 |
(S)-3-hydroxybutanoyl-CoA:NADP+ oxidoreductase | 1.1.1.157 | 152442 | 130608 | 2.95 | 666 | P < 0.01 |
prephenate:NAD+ oxidoreductase (decarboxylating) | 1.3.1.12 | 209257 | 186558 | 2.95 | 666 | P < 0.01 |
GDP-beta-L-fucose:beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R 4I-alpha-L-fucosyltransferase (configuration-inverting) | 2.4.1.65 | 22456 | 12648 | 2.95 | 648 | P < 0.01 |
GDP-beta-L-fucose:beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl-R 3-alpha-L-fucosyltransferase (configuration-inverting) | 2.4.1.152 | 22456 | 12648 | 2.95 | 648 | P < 0.01 |
S-adenosyl-L-methionine:tRNA (cytidine34/5-carboxymethylaminomethyluridine34-2′-O)-methyltransferase | 2.1.1.207 | 203298 | 180300 | 2.95 | 666 | P < 0.01 |
Ste24 endopeptidase | 3.4.24.84 | 8054 | 5270 | 2.94 | 642 | P < 0.01 |
dTDP-4-amino-4,6-dideoxy-alpha-D-glucose:2-oxoglutarate aminotransferase | 2.6.1.33 | 392 | 116 | 2.94 | 327 | P < 0.01 |
formate:NADP+ oxidoreductase | 1.17.1.10 | 9300 | 6092 | 2.93 | 618 | P < 0.01 |
[biotin carboxyl-carrier protein]-N6-carboxybiotinyl-L-lysine:acetyl-CoA:carboxytransferase | 2.1.3.15 | 344844 | 310616 | 2.92 | 666 | P < 0.01 |
2-hydroxy-2H-chromene-2-carboxylate—(3E)-4-(2-hydroxyphenyl)-2-oxobut-3-enoate isomerase | 5.99.1.4 | 48 | 17 | 2.92 | 88 | P < 0.01 |
acetyl-CoA:acetyl-CoA C-acetyltransferase | 2.3.1.9 | 152724 | 131247 | 2.92 | 666 | P < 0.01 |
1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]:FADH2 oxidoreductase (chlorinating) | 1.14.19.56 | 57 | 8 | 2.92 | 43 | P < 0.01 |
phosphoenolpyruvate:D-erythrose-4-phosphate C-(1-carboxyvinyl)transferase (phosphate-hydrolysing, 2-carboxy-2-oxoethyl-forming) | 2.5.1.54 | 201875 | 179097 | 2.91 | 666 | P < 0.01 |
SpoIVB peptidase | 3.4.21.116 | 158665 | 137029 | 2.90 | 666 | P < 0.01 |
ATP:adenosine 5′-phosphotransferase | 2.7.1.20 | 8550 | 5745 | 2.90 | 614 | P < 0.01 |
ATP:selenide, water phosphotransferase | 2.7.9.3 | 160218 | 139060 | 2.89 | 666 | P < 0.01 |
CTP:molybdenum cofactor cytidylyltransferase | 2.7.7.76 | 158341 | 136662 | 2.89 | 666 | P < 0.01 |
ATP phosphohydrolase (ABC-type, polar-amino-acid-importing) | 7.4.2.1 | 199197 | 176858 | 2.86 | 666 | P < 0.01 |
6-phospho-beta-D-glucosyl-(1->4)-D-glucose glucohydrolase | 3.2.1.86 | 151359 | 130522 | 2.85 | 666 | P < 0.01 |
D-mannonate:NAD+ 5-oxidoreductase | 1.1.1.57 | 156942 | 135744 | 2.83 | 666 | P < 0.01 |
acetyl-CoA:N-terminal L-alanyl-[S5 protein of 30S ribosome] N-acetyltransferase | 2.3.1.267 | 334249 | 305071 | 2.82 | 666 | P < 0.01 |
23S rRNA-uridine955/2504/2580 uracil mutase | 5.4.99.24 | 173982 | 152979 | 2.79 | 666 | P < 0.01 |
aspartyl aminopeptidase | 3.4.11.21 | 174811 | 154321 | 2.75 | 666 | P < 0.01 |
adenine aminohydrolase | 3.5.4.2 | 165689 | 145730 | 2.73 | 666 | P < 0.01 |
D-threo-aldose:NAD+ 1-oxidoreductase | 1.1.1.122 | 318 | 146 | 2.72 | 529 | P < 0.01 |
N-acyl-D-glucosamine-6-phosphate 2-epimerase | 5.1.3.9 | 169311 | 149193 | 2.71 | 666 | P < 0.01 |
(S)-2-haloacid halidohydrolase | 3.8.1.2 | 155173 | 135018 | 2.71 | 666 | P < 0.01 |
peptide-L-methionine:thioredoxin-disulfide S-oxidoreductase [L-methionine (S)-S-oxide-forming] | 1.8.4.11 | 312546 | 283931 | 2.71 | 666 | P < 0.01 |
S-adenosyl-L-methionine:precorrin-3B C17-methyltransferase | 2.1.1.131 | 161683 | 141568 | 2.70 | 666 | P < 0.01 |
S-adenosyl-L-methionine:cobalt-factor III C17-methyltransferase (ring contracting) | 2.1.1.272 | 161548 | 141442 | 2.69 | 666 | P < 0.01 |
23S rRNA-uridine2605 uracil mutase | 5.4.99.22 | 356849 | 324293 | 2.69 | 666 | P < 0.01 |
4-hydroxybenzoyl-CoA hydrolase | 3.1.2.23 | 8515 | 5695 | 2.67 | 538 | P < 0.01 |
phosphate-monoester phosphohydrolase (alkaline optimum) | 3.1.3.1 | 350542 | 317857 | 2.67 | 666 | P < 0.01 |
aceneuramate pyruvate-lyase (N-acetyl-D-mannosamine-forming) | 4.1.3.3 | 308399 | 281017 | 2.65 | 666 | P < 0.01 |
ADP-D-ribose ribophosphohydrolase | 3.6.1.13 | 323656 | 296452 | 2.65 | 666 | P < 0.01 |
Repressor LexA | 3.4.21.88 | 194850 | 174370 | 2.64 | 666 | P < 0.01 |
pectin pectylhydrolase | 3.1.1.11 | 273240 | 244908 | 2.64 | 666 | P < 0.01 |
S-methyl-5′-thioinosine:phosphate S-methyl-5-thio-alpha-D-ribosyl-transferase | 2.4.2.44 | 8312 | 5582 | 2.62 | 547 | P < 0.01 |
hydrogen:ferredoxin oxidoreductase | 1.12.7.2 | 8245 | 5720 | 2.61 | 609 | P < 0.01 |
phosphonoacetate phosphonohydrolase | 3.11.1.2 | 9209 | 6261 | 2.60 | 489 | P < 0.01 |
sortase A | 3.4.22.70 | 170941 | 151298 | 2.59 | 666 | P < 0.01 |
I will leave it to the professional microbiologists to make sense of the 190 enzymes above. I should point out that the levels with Long COVID are always higher than the control. I saw the same pattern with Salicylate sensitive – Data And Research, but not as extreme (as with much fewer significant enzymes).
Bacteria Found Significant
The strongest associations are shown below. It is interesting to note that the t-scores are lower for bacteria than for enzymes. The clustering by enzymes was beneficial. We expect less than 2 false positives in this list. Note that the degrees of freedom (Df) is reflected of frequency found. df=38 means that 40 out of 668 samples reported this bacteria.
Tax rank | Taxa Name | With Long COVID | Without Long COVID | T-Score | Df | Probability |
species | Faecalibacterium prausnitzii | 138151 | 109673 | 3.78 | 666 | P < 0.001 |
genus | Planococcus | 41 | 25 | 3.89 | 118 | P < 0.001 |
genus | Anaeroplasma | 19328 | 3766 | 3.49 | 74 | P < 0.001 |
class | Mollicutes | 5774 | 2610 | 3.65 | 642 | P < 0.001 |
genus | Coriobacterium | 173 | 32 | 5.41 | 38 | P < 0.001 |
species | Coriobacterium glomerans | 173 | 32 | 5.41 | 38 | P < 0.001 |
genus | Kushneria | 54 | 28 | 3.62 | 148 | P < 0.001 |
phylum | Tenericutes | 5774 | 2610 | 3.65 | 642 | P < 0.001 |
order | Anaeroplasmatales | 19328 | 3766 | 3.49 | 74 | P < 0.001 |
family | Anaeroplasmataceae | 19328 | 3766 | 3.49 | 74 | P < 0.001 |
species | Planococcus columbae | 41 | 24 | 4.85 | 108 | P < 0.001 |
The less significant ones are shown below:
Tax rank | Taxa name | With Long COVID | Without Long COVID | T-Score | Df | Probability |
species | Lactobacillus letivazi | 28 | 11 | 3.93 | 12 | P < 0.01 |
species | Clostridium fallax | 84 | 22 | 3.53 | 32 | P < 0.01 |
species | Corynebacterium xerosis | 755 | 90 | 3.34 | 48 | P < 0.01 |
species group | Pseudomonas syringae group | 60 | 25 | 3.17 | 46 | P < 0.01 |
species | Corynebacterium kutscheri | 186 | 34 | 3.12 | 33 | P < 0.01 |
genus | Comamonas | 289 | 51 | 3.11 | 61 | P < 0.01 |
species | Peptoniphilus indolicus | 150 | 30 | 3.11 | 67 | P < 0.01 |
species | Prevotella oulorum | 87 | 52 | 3.06 | 72 | P < 0.01 |
order | Sphingobacteriales | 40382 | 31662 | 2.99 | 667 | P < 0.01 |
class | Sphingobacteriia | 40382 | 31662 | 2.99 | 667 | P < 0.01 |
family | Azonexaceae | 60 | 20 | 2.98 | 60 | P < 0.01 |
genus | Dechloromonas | 60 | 20 | 2.98 | 60 | P < 0.01 |
family | Rhodocyclaceae | 71 | 50 | 2.97 | 413 | P < 0.01 |
genus | Marinospirillum | 42 | 28 | 2.87 | 156 | P < 0.01 |
species | Euzebya tangerina | 64 | 46 | 2.79 | 370 | P < 0.01 |
class | Nitriliruptoria | 64 | 46 | 2.79 | 370 | P < 0.01 |
order | Euzebyales | 64 | 46 | 2.79 | 370 | P < 0.01 |
family | Euzebyaceae | 64 | 46 | 2.79 | 370 | P < 0.01 |
genus | Euzebya | 64 | 46 | 2.79 | 370 | P < 0.01 |
species | Clostridium caliptrosporum | 26 | 17 | 2.72 | 37 | P < 0.01 |
genus | Pedobacter | 12917 | 9686 | 2.72 | 656 | P < 0.01 |
species | Sphingobacterium bambusae | 480 | 315 | 2.70 | 579 | P < 0.01 |
species | Prevotella corporis | 1883 | 645 | 2.69 | 315 | P < 0.01 |
species | Dechloromonas hortensis | 34 | 21 | 2.68 | 56 | P < 0.01 |
family | Sphingobacteriaceae | 35765 | 28616 | 2.59 | 666 | P < 0.01 |
At this point, our first set of bacteria to look at are ones with a high df (and thus most commonly seen). This is a short list when we drop parent and child with the same numbers:
Tax rank | Taxa name | With Long COVID | Without Long COVID | TScore | Df | Probability |
order | Sphingobacteriales | 40382 | 31662 | 2.99 | 667 | P < 0.01 |
species | Faecalibacterium prausnitzii | 138151 | 109673 | 3.78 | 666 | P < 0.001 |
family | Sphingobacteriaceae | 35765 | 28616 | 2.59 | 666 | P < 0.01 |
genus | Pedobacter | 12917 | 9686 | 2.72 | 656 | P < 0.01 |
phylum | Tenericutes | 5774 | 2610 | 3.65 | 642 | P < 0.001 |
Comparing to published studies above
We have no agreement on identification of significant bacteria. The only bacteria in common was Faecalibacterium prausnitzii. This bacteria was cited in just one Pubmed studies on Long COVID. Many studies reported on it during the active COVID infection. This study reported it was lower. We found that it was higher. That study sample size was considerable smaller than us : 106 with Long COVID and 68 Control; they did not mention the significance level but used the term often seen when there was poor significance: “were characterized by”. This study cites “Faecalibacterium prausnitzii showed the largest inverse correlations with PACS at 6 months.” We are dealing with samples with different periods since onset.
The absence of bacteria in common is not unexpected given differences in methodologies. This is often seen when multiple studies on the same condition are done, non-replication of results. I refer the reader to this story
Three blind microbiologists attempt to describe the microbiome of an elephant…
See Blind men and an elephant
Comparing Suggestions
We have suggestions generated from the US National Library of Medicine studies, and we also have suggests from this analysis. These suggestions are generated by the Fuzzy Logic Artificial Intelligence on the Microbiome Prescription site. How do they compare?
Running with everything that is suggested (including prescription items) by both sets of data we found:
- Agreement on 1255 items that will help
- Disagreement on 396 items (one says help, one says hurt)
This is 76% agreement on suggestions that would help. This is surprisingly good given that Faecalibacterium prausnitzii are reported in opposite directions between these two sets. The best agreement was for:
- Drug or “Non-drug” at 90.5% – with 95 items considered
- Prescription other at 93.8% – with 933 items considered
This was not surprising because the data density for these two is good. For many other things, the data density is sparse — for example, for Prebiotics, Amino acids and Probiotics. There is almost no literature on how they impact many of the bacteria cited.
How to Use this data?
The root problem is having insufficient data in many vectors. As a fuzzy logic engineer, this does not concern me — we will simply make the best use of available data in the belief that it is better than working from no data.
The system on Microbiome Prescription uses the consensus system for treatment suggestions. You can process a microbiome using PubMed studies, process it again with the above data, and then get a list where the suggestions are in agreement. At present, the microbiome sample must be processed thru Biomesight because that is how the items of significance were detected. In time, other labs could reach sufficient data to get results.
To illustrate this process, I have done a video below using a sample from someone with Long COVID.
Related Blog Posts for those who are interested:
- Special Studies on Symptoms caused by Bacteria – v.2
- Histamine Release – Literature Review And Speculation
- Salicylate sensitive – Data And Research
Data Availability: The samples and symptoms are available at: Microbiome Prescription Citizen Science Data Share
Postscript – and Reminder
I am not a licensed medical professional and there are strict laws where I live about “appearing to practice medicine”. I am safe when it is “academic models” and I keep to the language of science, especially statistics. I am not safe when the explanations have possible overtones of advising a patient instead of presenting data to be evaluated by a medical professional before implementing.
I cannot tell people what they should take or not take. I can inform people items that have better odds of improving their microbiome as a results on numeric calculations. I am a trained experienced statistician with appropriate degrees and professional memberships. All suggestions should be reviewed by your medical professional before starting.
The answers above describe my logic and thinking and is not intended to give advice to this person or any one. Always review with your knowledgeable medical professional.
Recent Comments